COFEPRIS opens an ANVISA equivalence pathway for medicines in Mexico. Scope, filing requirements and the 45-business-day review, explained.
[Mexico] 5 rules of the new ANVISA equivalence pathway Read More »
Date: January 17th, 2026 The Mexican government officially updated the General Health Law, specifically Article 376. These changes are designed
[Mexico] Streamlined regulations and enhanced safety for medical imports in Mexico Read More »
Date: March 4, 2026 Mexico has begun operational implementation of its fast-track pathway for medical device registration, allowing eligible products
